Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Green Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel green synthesis process for 2-fluoro-3-nitrobenzoic acid reduces waste and ensures scalable supply for pharmaceutical intermediates.
Patent CN102816116B details a green synthesis of 6-hydroxy-2(1H)-quinolinone using Gemini surfactants, offering cost reduction and scalable manufacturing for cardiovascular intermediates.
Patent CN110878106B details a green synthesis of ferrocenyl Mannich bases using recyclable ionic liquids, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel two-step catalytic method converts oleic acid to azelaic acid with high yield and reduced waste, offering a reliable supply chain solution for pharmaceutical and polymer industries.
Patent CN106397440A reveals a green synthesis route for Istradefylline using dimethyl carbonate, offering high purity and reduced toxicity for reliable pharmaceutical intermediate supply chains.
Patent CN102134197B details a green synthesis method for Schiff bases using recyclable carboxylic acid ionic liquids, offering high yields and simplified purification for industrial applications.
Patent CN103772302A reveals a recyclable Cu2O/polymer system for triazole synthesis in water, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114394913A reveals a metal-free heteropoly acid catalytic route for oxime ether derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109912474A reveals lactic acid catalyzed route. High purity, scalable, cost-effective intermediate manufacturing.
Patent CN102010376A reveals a green aqueous synthesis for quinoxalines using biodegradable ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105367535B reveals trisulfonic acid ionic liquid catalyst for high-purity acridine derivatives manufacturing with reduced waste and cost.
Patent CN102040561A reveals a green synthesis method for benzotriazole UV absorbers using acidic ionic liquids, offering high yields and reduced environmental impact for polymer additive manufacturing.
Patent CN101289378A details a solvent-free chalcone synthesis using recyclable ionic liquids, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN109369519B reveals a high-yield green route for 2-chloro-3-cyanopyridine using bis(trichloromethyl) carbonate, offering cost reduction and supply reliability.
Novel method for clarithromycin intermediate using lactam salts. Reduces waste, improves safety. Reliable supplier for API intermediates.
Patent CN101314574B reveals a green aqueous method for acylated enamines using phosphotungstic acid, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN103664599A details a green esterification route for TMPTA using molecular sieves and alkanes, achieving >98% purity and >95% yield for coating applications.
Novel patent CN105111268A enables greener steroid intermediate production with reduced waste and enhanced supply chain stability for global pharmaceutical manufacturers.
Patent CN109369521B details a green 2-chloroquinoline synthesis using BTC. Discover cost-effective, high-purity manufacturing solutions for pharmaceutical intermediates.